bibliographicCitation |
Dakin H, Sherman M, Fung S, Fidler C, Bentley A. Cost effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B from a Canadian public payer perspective. Pharmacoeconomics. 2011 Dec;29(12):1075–91. doi: 10.2165/11589260-000000000-00000. PMID: 22077579. |